Have a feature idea you'd love to see implemented?
Let us know!
ESTA Establishment Labs Holdings Inc
Price (delayed)
$41.32
Market cap
$1.15B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.11
Enterprise value
$1.3B
Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative
Highlights
Establishment Labs Holdings's gross margin has increased by 2% YoY
Establishment Labs Holdings's quick ratio has decreased by 16% YoY but it has increased by 6% QoQ
The net income has declined by 37% year-on-year
Establishment Labs Holdings's EPS has decreased by 27% YoY
Key stats
What are the main financial stats of ESTA
Market
Valuations
Earnings
Shares outstanding
27.94M
Market cap
$1.15B
Enterprise value
$1.3B
Price to earnings (P/E)
N/A
Price to book (P/B)
25.25
Price to sales (P/S)
7.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.57
Revenue
$151.35M
EBIT
-$66.58M
EBITDA
-$60.95M
Free cash flow
-$81.26M
Per share
Balance sheet
Liquidity
EPS
-$3.11
Free cash flow per share
-$2.91
Book value per share
$1.64
Revenue per share
$5.42
TBVPS
$9.84
Total assets
$285.09M
Total liabilities
$240.07M
Debt
$196.72M
Equity
$45.02M
Working capital
$144.24M
Debt to equity
4.37
Current ratio
4.44
Quick ratio
2.74
Net debt/EBITDA
-2.33
Margins
Efficiency
Dividend
EBITDA margin
-40.3%
Gross margin
66%
Net margin
-55%
Operating margin
-40.5%
Return on assets
-29.6%
Return on equity
-220.7%
Return on invested capital
-18.4%
Return on capital employed
-27.4%
Return on sales
-44%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ESTA stock price
How has the Establishment Labs Holdings stock price performed over time
Intraday
-2.75%
1 week
-7.48%
1 month
-2.29%
1 year
0.44%
YTD
59.6%
QTD
-4.51%
Financial performance
How have Establishment Labs Holdings's revenue and profit performed over time
Revenue
$151.35M
Gross profit
$99.95M
Operating income
-$61.33M
Net income
-$83.2M
Gross margin
66%
Net margin
-55%
ESTA's net margin has dropped by 60% year-on-year and by 3.6% since the previous quarter
ESTA's operating margin has dropped by 58% year-on-year but it is up by 4% since the previous quarter
The net income has declined by 37% year-on-year
The operating income has declined by 35% year-on-year but it has grown by 7% since the previous quarter
Growth
What is Establishment Labs Holdings's growth rate over time
Valuation
What is Establishment Labs Holdings stock price valuation
P/E
N/A
P/B
25.25
P/S
7.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.57
Establishment Labs Holdings's EPS has decreased by 27% YoY
The price to book (P/B) is 66% lower than the 5-year quarterly average of 76.6 and 20% lower than the last 4 quarters average of 32.5
Establishment Labs Holdings's equity has decreased by 21% QoQ and by 18% YoY
The P/S is 18% less than the 5-year quarterly average of 9.6 but 9% more than the last 4 quarters average of 7.2
Establishment Labs Holdings's revenue has decreased by 15% YoY and by 2.9% from the previous quarter
Efficiency
How efficient is Establishment Labs Holdings business performance
Establishment Labs Holdings's ROS has plunged by 76% YoY and by 2.1% from the previous quarter
The ROE has soared by 71% YoY but it has contracted by 7% from the previous quarter
Establishment Labs Holdings's return on invested capital has decreased by 19% YoY but it has increased by 4.2% QoQ
The company's return on assets fell by 9% YoY
Dividends
What is ESTA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ESTA.
Financial health
How did Establishment Labs Holdings financials performed over time
The company's total assets is 19% higher than its total liabilities
Establishment Labs Holdings's quick ratio has decreased by 16% YoY but it has increased by 6% QoQ
Establishment Labs Holdings's current ratio has decreased by 8% YoY but it has increased by 4.7% from the previous quarter
The debt to equity has grown by 30% YoY and by 27% from the previous quarter
Establishment Labs Holdings's equity has decreased by 21% QoQ and by 18% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.